A recent study from Cornell University offers a new perspective on how the chemotherapy drug etoposide delays and kills vital enzymes that support the growth of cancer cells.
According to a study published in the American Journal of Medical Quality, delaying antibiotic treatment beyond 60 minutes from the time of fever detection does not reduce the short-term chance of survival in cancer patients with neutropenic fever.